RXST - RxSight, Inc. Последние новости | Finranks

26.02.2026

RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript

26.02.2026

RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates

RxSight, Inc. (RXST) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to earnings of $0.03 per share a year ago.

18.02.2026

Earnings Preview: RxSight, Inc. (RXST) Q4 Earnings Expected to Decline

RxSight (RXST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

11.02.2026

RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

ALISO VIEJO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the fourth quarter and full year 2025 after the market close on Wednesday, February 25, 2026. The company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

22.01.2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

20.01.2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

15.01.2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

NEW YORK, Jan. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Видео

No Data

There is no data to display

Повышения / Понижения рейтинга

Тикер	Фирма	Изменение рейтинга	Целевая цена	Дата
RXST	Morgan Stanley	Equal Weight	undefined >> $9	July 15th 2025
RXST	Jefferies	Hold	undefined >> $9	July 10th 2025
RXST	Oppenheimer	Perform	undefined >> undefined	July 9th 2025
RXST	Wells Fargo	Equal Weight	undefined >> $9	July 9th 2025
RXST	BTIG Research	Neutral	undefined >> undefined	July 9th 2025
RXST	Wells Fargo	Overweight	undefined >> $25	May 19th 2025
RXST	Piper Sandler	Neutral	undefined >> $18	April 15th 2025
RXST	UBS	Neutral	undefined >> $16	April 9th 2025

Пресс-релизы

22.01.2026

RxSight, Inc. (RXST)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

RxSight, Inc. (RXST)

RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript

RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates

Earnings Preview: RxSight, Inc. (RXST) Q4 Earnings Expected to Decline

RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST